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ABSTRACT
Background: Liver fibrosis is an effect from continuous fibrogenesis and fibrolysis process. During fibrogenesis, 
MMP-2 and TIMP-2 that produced by hepatic stellate cell (HSC) have a role to regulate extracellular matrix 
(ECM) homeostastic. Otherwise, curcumin inhibits both MMP-2 and TIMP-2 expression and enhances HSC 
apoptosis, thus inhibit fibrogenesis. Role of curcumin, MMP-2, and TIMP-2 in a fibrolysis process has not been 
widely studied. This study aimed to determine the correlation between curcumin administration and the decline 
of MMP-2 and TIMP-2 on rat model of liver fibrosis. 
Method: This is an experimental study done in male Wistar rats. There are 8 groups consist of 4 rats each. 
Both control and intervention group were exposed to CCl4 1 cc/kgBW intraperitoneally 2 times per week for 
9 consecutive weeks to form F3 fibrosis. Negative control group was injected with normal saline. After CCl4 
injection, control group was given curcumin solvent as placebo while intervention groups were given curcumin 
200 mg/kgBW for 2, 5, and 9 weeks. Statistical analysis then conducted in the end of study.
 Results: MMP-2 and TIMP-2 were remarkably increased in positive control group, but found decreased in 
control group 5 and 9. There are remarkable decrease of MMP-2 and TIMP-2 serum level in intervention group 2, 5, 
and 9, but MMP-2 and TIMP-2 level was significantly lower in intervention group 2 compared to the control group.
Conclusion: MMP-2 and TIMP-2 serum level were decreased after giving of curcumin for 2 weeks. The 
duration of curcumin administration correlated with decrease of TIMP-2 serum level but not correlated with 
MMP-2 serum level in rat model of liver fibrosis. 
Keywords: Carbon tetrachloride, curcumin, MMP-2, TIMP-2, rat model of liver fibrosis
ABSTRAK
Latar belakang: Fibrosis hati merupakan hasil dari proses fibrogenesis dan fibrolisis. Pada proses fibrogenesis, 
MMP-2 dan TIMP-2 yang diproduksi sel stellata hati (HSC), mengatur homeostasis matriks ekstraseluler (MES). 
Kurkumin menghambat ekspresi MMP-2 dan TIMP-2, serta mendorong apoptosis HSC sehingga menghambat 
fibrogenesis. Peran kurkumin, MMP-2 dan TIMP-2 dalam proses fibrolisis belum banyak diteliti. Penelitian ini 
bertujuan mengetahui hubungan antara pemberian kurkumin terhadap penurunan MMP-2 dan TIMP-2 pada 
tikus model fibrosis hati.
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 Metode: Penelitian eksperimental pada tikus jantan strain wistar. Terdapat 8 kelompok, masing-masing 
terdiri dari 4 tikus. Kelompok KP dipapar CCl4 1cc/kgbb 2x perminggu intraperitoneal selama 9 minggu untuk 
membentuk fibrosis F3. Kelompok KN diinjeksi Normal Salin. Setelah diinjeksi CCl4, Kelompok Kontrol (KK2, 
KK5, KK9) diberikan plasebo dan Kelompok Perlakuan (KP2, KP5 dan KP9) diberikan kurkumin 200mg/kgbb 
2,5 dan 9 minggu. Dilakukan analisis kadar serum MMP-2 dan TIMP-2 dengan menggunakan uji T independen, 
uji pengaruh pemberian dan lama pemberian kurkumin dengan ANOVA. 
Hasil: Terdapat peningkatan signifikan kadar serum MMP-2 dan TIMP-2 pada kelompok KP, dan penurunan 
signifikan kadar serum MMP-2 dan TIMP-2 pada kelompok KK5 dan KK9. Pada kelompok kurkumin, terdapat 
penurunan signifikan kadar serum MMP-2 dan TIMP-2 pada KP2, KP5, dan KP9, dan pada perbandingan 
kelompok plasebo dengan kelompok yang diberikan kurkumin, terdapat penurunan signifikan kadar MMP-2 
dan TIMP-2 pada KP2.
 Simpulan: Terdapat penurunan signifikan kadar serum MMP-2 dan TIMP-2 pada pemberian kurkumin 
selama 2 minggu. Lama pemberian kurkumin berkorelasi dengan penurunan kadar serum TIMP-2 tetapi tidak 
signifikan pengaruhnya pada kadar serum MMP-2 tikus model fibrosis hati. 
Kata kunci: karbon tetraklorida, kurkumin, MMP-2, TIMP-2, tikus model fibrosis hati
INTRODUCTION
Liver fibrosis is an effect from continuous 
fibrogenesis and fibrolysis process. At the beginning of 
fibrosis, several hepatotoxic factors insult hepatocytes, 
induce inflammatory response, and activate quiescent 
hepatic stellate cell (HSC) to activated HSC (aHSC). 
Later, aHSC would produce huge amount of 
extracellular matrix (ECM) protein, mainly collagen 
type I and III, that increase the stiffness of ECM.1 
Liver fibrosis is a dynamic process which involve 
deposition and degradation of ECM. A balance 
between matrix metalloproteinase (MMP), an enzyme 
to degrade ECM, and its specific inhibitor known as 
tissue inhibitor matrix metalloproteinase (TIMP) is 
important to regulate homeostasis of liver connective 
tissue.2 Previous study on rat by Iredale et al and Issa 
et al showed that improvement in fibrolysis process 
towards normal liver histology takes about 4-6 weeks 
after its fibrosing etiology removed. This showed that 
liver fibrosis is a reversible process and further known 
as spontaneous resolution.3
MMPs that largely produced by HSC is MMP-2 
which its act on ECM degradation was regulated 
by TIMP-2. MMP-2 and TIMP-2 level in blood 
was corelate to its concentration in liver and also 
corelate to fibrosis degree.4 To induce liver fibrosis in 
experimental animal, carbon tetrachloride (CCl
4
) as a 
hepatotoxic agent is widely used. CCl
4
 is metabolized 
by cytochrome P450 2EI to form two radicals: reactive 
trichloromethyl (CCl3
-) and trichloromethyl peroxyl 
(CCl3O2). Those radical will bond to DNA, fat, protein, 
and carbohydrate to cause lipid peroxidation, cell 
necrosis and apoptosis, and collagen deposition in liver. 
Kupffer cell which activated by those free radicals will 
produce several proinflammatory mediator that induce 
inflammation cascade.5
Curcumin was previously known to induce HSC 
apoptosis by inhibit transforming growth factor 
(TGF)- β1 and platelet derived growth factor (PDGF).6 
Recent study by Banerji, et al showed a significant 
inhibitory effect of curcumin on MMP-2 activation. 
Curcumin inhibitor MMP-2 activity by down regulate 
expression of MT1-MMP, an enzyme which together 
with TIMP-2, activate pro-MMP-2 to MMP-2. Lower 
MMP-2 activity will lead reduce liver basal membrane 
degradation during liver fibrogenesis.7 
METHOD
This is an in vivo experimental study in Wistar 
strain rat with post test control group design and 
randomization. Intervention consist of CCl
4
 induction 
and curcumin administration. Sample analysis of MMP-
2 and TIMP-2 level was done in physiology laboratory 
Faculty of Medicine, Brawijaya University, Malang. 
This study was conducted in June to November 2016. 
We divide subject into 8 groups with 4 rats in each 
group. Negative control group was given normal saline 
injection twice a week for 9 weeks, while positive 
control group was given CCl
4
 injection 1 cc/kgBW 
twice a week intraperitoneally for 9 weeks to form 
a F3 fibrosis, then continued by placebo injection of 
curcumin solvent CMC Na 1% 1 cc/kgBW daily for 
two weeks (CG2), five weeks (CG5), and nine weeks 
(CG9). Other intervention groups were given CCl
4
 
injection for 9 weeks than continued by 200 mg/kgBW/
day of curcumin for two weeks (IG2), five weeks 
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(IG5), and nine weeks (IG9). Rats were terminated 
after the last 72 hours injection. This study was 
ethically approved by Ethical Committee of Faculty 
of Medicine, Brawijaya University. 
Inclusion criteria is male rat, aged + 3 months, 
weight of 150-250 grams, and physically active. Drop 
out criteria is rat that refuse to eat, sick, and died during 
intervention period. Independent variable were CCl
4 
exposure and curcumin administration and duration, 
while dependent variable were MMP-2 and TIMP-2 
serum level measured using Rat MMP-2/ TIMP-2 
Platinum ELISA BMS635/BMS635TEN kit from 
eBioscience.
Statistical analysis was done using IBM SPSS 
statistics, version 22.0 for windows. We use 95% of 
confidence interval (α = 0,05). A normal distribution 
and homogenous variation data will be analyzed using 
parametric analysis Two Way ANOVA and Post Hoc 
Tukey. If not, non-parametric analysis using Kruskal 
Wallis and Mann Whitney is used. We also done a 
Pearson correlation analysis and independent t-test. 
RESULTS
After CCl
4 
administration for 9 weeks, F3 fibrosis 
(septal fibrosis) was expected which also followed 
by increase of MMP-2 and TIMP-2 serum level in 
intervention group compared to normal group. Here 
was the different of MMP-2 and TIMP-2 increasement 
level between intervention and normal group: 
Otherwise, comparison between positive control group 
to IG5 and IG 9 showed a significant lower MMP-2 
level with p < 0,05. It can be concluded that MMP-
2 level was significantly lower in week 5 and 9 of 
intervention.
From Figure 1, it showed that a significant increase 
in MMP-2 level in fibrosis was occurred in rat model 
that induced by CCl
4
 for 9 weeks. 
In Figure 2, we compare positive control group 
to control group that administered curcumin solvent. 
There were no significant difference in mean MMP-
2 level between positive control group and IG2. 
Figure 1. Histogram of mean MMP-2 level in positive and 
negative control group (NC: negative control; PC: positive 
control)
In all group that administered curcumin, MMP-2 
level was found to be significantly lower (p < 0,05). 
This result showed that curcumin administration for 
2, 5, and 9 weeks have been proven to significantly 
reduce MMP-2 level.
Figure 2. Comparison of MMP-2 level between positive control 
(PC) group and control group (CG)
Table 1. Test of interaction between curcumin administration 
and its duration to MMP-2 serum level
Intervention Mean ± SD P
CG2 9.03 ± 1.32
IG2 6.34 ± 1.53
CG5 3.75 ± 0.54 0.015
IG5 3.34 ± 0.56
CG9 3.71 ± 0.89
IG9 4.34 ± 1.01
Note: if mean ± SD column contains 2 different alphabet, it means that there 
is a significant difference (p < 0.05). But if it contains same alphabet, it means 
that there is no significant different (p > 0.005) 
We than conduct a statistical analysis using Two 
Way ANOVA followed by Post Hoc Tukey analysis 
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Figure 3. Comparison of MMP-2 level between positive control 
(PC) group and intervention group (IG)
Volume 19, Number 1, April 2018 13
Effects of Curcumin Against MMP-2 and TIMP-2 Serum Level on Rat Model of Liver Fibrosis Resolution Process
to investigate the interaction between curcumin 
administration and its duration after the test of 
normality and homogeneity (Table 1). 
Result from ANOVA test showed a p value of 
0,015 so it can be concluded that there were significant 
effect from curcumin administration and its duration to 
MMP-2 serum level. In other words, a significant lower 
MMP-2 level was correlate to curcumin administration 
and its duration. 
Based on Tukey test 5% in Table 1, in comparison 
between CG2 and IG2, a significant lower MMP-2 
level was found after curcumin administration in 
fibrosis rat model. A comparison between both CG5 
to IG5 and GC9 to IG9 did not showed a significant 
reduction in MMP-2 level. This result explained that 
curcumin administration for 5 and 9 weeks were not 
significant to reduce MMP-2 level in liver fibrosis. 
Mean MMP-2 levels are shown in following histogram: 
To know whether spontaneous resolution from 
TIMP-2 level improvement, we compare the result 
from positive control group to group that administered 
with curcumin solvent (CG) as shown in Figure 6. 
There was lower mean TIMP-2 level in CG5 and CG9 
(p = 0,000 and p = 0,012, respectively). This result 
showed a significant reduction in TIMP-2 level after 
CCl
4 
administration was stopped for 5 and 9 weeks. 
Curcumin administration effect in lowering TIMP-2 
level could be analyze by comparing positive control 
group to intervention group (IG). From Figure 7, a 
significant reduction of TIMP-2 level (p < 0,05) was 
found between positive control group and IG2, IG5, 
and IG9. This prove that curcumin administration for 2, 
5, and 9 weeks can reduce TIMP-2 level significantly.
To investigate TIMP-2 level in fibrosis rat model, an 
independent t-test was conducted. As shown in Figure 
5, we found a significant increase of serum TIMP-2 
level after CCl
4 
induction for 9 weeks.
Figure 4. Histogram of mean MMP-2 level in all intervention group 
Figure 5. Histogram of mean TIMP-2 level in negative control 
(NC) and positive control (PC) group
Figure 6. Comparison of TIMP-2 level between positive control 
group and control group that have been administered curcumin 
solvent (PC: positive control; CG: control group)
Figure 7. A Comparison of TIMP-2 level between positive 
control (PC) group and curcumin intervention group (IG)
Table 2. A test of interaction between curcumin administration 
and its duration to serum TIMP-2 level
Intervention Mean ± SD p value
CG2 6.96 ± 0.55
IG2 5.4 ± 0.58
CG5 4.79 ± 0.44 0.015
IG5 3.81 ± 0.51
CG9 5.78 ± 0.62
IG9 3.15 ± 0.82
Note: if mean ± SD column contains 2 different alphabet, it means that there 
is a significant difference (p < 0.05). But if it contains same alphabet, it means 
that there is no significant different (p > 0.005) 
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Figure 7. A Comparison of TIMP-2 level between positive control (PC) group and curcumin 
intervention group (IG) 
 
Figure 8. Mean TIMP-2 level in all intervention group 
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We then conduct Two Way ANOVA and Post Hoc 
Tukey test as shown in Table 2. From ANOVA test, a p 
value of 0,039 showed a significant improvement effect 
of curcumin administration and its duration to TIMP-
2 level. In Tukey analysis, a significant reduction in 
TIMP-2 level was found a comparison between CG2 
to IG2 and CG9 to IG9 (Figure 8). This showed that 
curcumin administration for 2 and 9 weeks lowered 
fibrosis rat model TIMP-2 level. 
From previous study, CCl
4
 intraperitoneal injection 
for 9 weeks showed a formation of F3 fibrosis in 
positive control group with only one subject forming 
F2 fibrosis, while negative control group that given 
saline injection form F0 fibrosis in three rats and F1 
fibrosis in one rats, using histologic Hematoxylin-
Eosin examination.10
In this study, we found an increasing MMP-2 level 
in fibrosis rat model that statistically significant (p < 
0,005). This was consistent to study by Liang et al, 
which MMP-2 concentration significantly increasing 
in liver F2-F4 fibrosis.11 This study also showed that 
a reduction in both MMP-2 and TIMP-2 level in CG5 
and CG9 that means TIMP-2 level reduced after CCl
4
 
administration stopped for 5 weeks. A study by Issa et 
al revealed that aHSC was quickly undergo apoptosis 
in four weeks after liver injury by CCl
4 
was stopped. 
following HSC apoptosis, MMP-2 and TIMP-2 would 
further reduced.12 This is consistent with this study 
result in CG5 group. By removing the insult to liver 
injury, CCl
4
 in this study, a lower MMP-2 and TIMP-2 
could be found lower after 5 weeks. 
Curcumin was predicted to improve liver injury 
and prevent liver cirrhosis. Various liver injury caused 
by virus, alcoholism, and other toxin increase fibrosis 
progressivity in which normal liver tissue replaced by 
collagen-rich ECM that could lead to cirrhosis. HSC 
played an important role in fibrosis development. 
After liver cell injury, HSC is activated and proliferate 
to produce several cytokines, chemokines, growth 
factors, profibrogenic cytokines, and metalloproteinase 
inhibitors.13
Latest evidence showed that liver fibrosis is a 
reversible process, related to HSC apoptosis. In this 
situation, curcumin was predicted to act as antioxidant, 
antiinflammation, antifibrosis, and antiproliferative 
agent. 
Curcumin act as antifibrosis agent by reducing 
oxidative stress, inhibit HSC activation, and induce 
activated HSC apoptosis. From the last mechanism, 
MMP-2 expression and serum level could reduce 
and followed by TIMP-2. Curcumin also reduce 
MT1-MMP that further lower MMP-2 activation. 
Antiinflammation effect of Curcumin was proven by 
its role in reducing TGF-β1 and PDGF as activating 
and mitogenic factors from HSC so that it lead to HSC 
apoptosis.
Finally, curcumin administration was predicted to 
improve liver fibrognesis by lowering MMP-2 and 
TIMP-2 level in fibrosis rat liver model. The result of 
this study showed an increase in MMP-2 and TIMP-2 
Figure 8. Mean TIMP-2 level in all intervention group (IG)
Table 3. Correlation between curcumin administration duration 
and MMP-2 and TIMP-2 level
Correlation Coeff. Correlation p
Curcumin administration duration and 
MMP-2 level
-0.468 0.125
Curcumin administration duration and 
TIMP-2 level
-0.815 0.001
A correlation study using Pearson correlation test 
was done (Table 3). There was significant correlation 
between curcumin administration and TIMP-2 level (r 
= -0,815; p = 0,001), but no significant correlation to 
MMP-2 level (p > 0,005)
DISCUSSION
This study was using CCl
4 
as fibrosis inducer 
in rat liver tissue. CCl
4 
administration for 9 weeks 
was aimed to induce septal fibrosis (F3). CCl
4
 is 
metabolized by cytochrome P450 2E1 to form a 
reactive trichloromethyl (CCl3
-) and trichloromethyl 
peroxyl (CCl3O2) radicals. Both radicals would further 
bond to DNA, lipid, protein, and carbohydrate to 
cause lipid peroxidation, cell necrosis, and collagen 
deposition in liver. Kupffer cell was later activated by 
those free radicals and further produce proinflammatory 
mediators that trigger inflammatory cascade.9
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intervention group (IG) 
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level in positive control group after CCl
4
 administration. 
In contrast, a significant lower MMP-2 and TIMP-2 
level was found after curcumin intervention, indicate 
an improvement in liver fibrosis grade. 
Curcumin was safe and effective to be used as both 
preventive and curative agent or various disease. Yet, 
curcumin has a poor bioavailability when mixed with 
water. In a study that administer curcumin 2 g/kgBW in 
rat, a peak serum concentration of 1.35 + 0.23 μg/mL 
was found in 0.83 hours, while similar dose in human 
showed nearly no curcumin detected (0.006 ± 0.005 
μg/mL) in the first hour of observation.14
Curcumin accumulation was largely found in bowel 
and liver tissue, indicate that it should has effect on 
gastrointestinal diseases. Liver is the main organ to 
metabolize curcumin. After it absorbed, curcumin 
would then conjugate to form curcumin glucuronide 
or curcumin sulfate.12 Nowadays, nanoemulsion is a 
substance that could increase curcumin bioavailability. 
Carboxymethyl cellulose (CMC) used as curcumin 
emulsifier because its polyphenolic component was 
water insoluble. 13
From this study, a significant lower MMP-2 and 
TIMP-2 level were found in rats that given curcumin 
for 2 weeks (IG2) compared to curcumin solvent only 
(CG2) with p = 0,019 (p < 0,05), but insignificant in 
comparison of IG5 and IG9 to CG5 and CG9. It can be 
concluded that curcumin effect to lower MMP-2 level 
was optimal in two week-administration. 
In intervention group of 5 and 9 weeks, insignificant 
results were explained as an effect of maximum aHSC 
apoptosis following 5 week CCl
4
 injection, so that no 
MMP-2 reduction observed in both intervention group. 
Correlation analysis between curcumin duration 
and MMP-2 level showed insignificant correlation. In 
contrast, TIMP-2 and curcumin administration was 
significantly corelate with correlation coefficient of 
-0,815 and p < 0,05. This indicate a strong correlation 
that the longer curcumin administration duration, the 
lower TIMP-2 level could be. 
CONCLUSION
There were increase of MMP-2 and TIMP-2 level in 
liver fibrosis rat model after CCl
4
 exposure for 9 weeks. 
CCl
4
 termination then proved to reduce MMP-2 and 
TIMP-2 level in liver fibrosis. Curcumin administration 
lead to lower MMP-2 and TIMP-2 level in liver fibrosis 
rat model, optimally during the second week. Duration 
of curcumin administration only correlate to lower 
TIMP-2 serum level, not in MMP-2 serum level. 
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